#Saudi Arabia #Riyadh #Aphranel #CaHA Filler #MagiCCrystal

Aphranel Debuts Innovative CaHA Filler at SAAM 2025

Aphranel, a pioneering aesthetic brand from Shanghai Moyang Biotechnology, made its inaugural presentation at the 4th Saudi Arabia Aesthetic Medicine Scientific Congress (SAAM 2025) held in Riyadh. The event highlighted Aphranel's flagship product, the MagiCCrystal Filler, which is composed of calcium hydroxyapatite (CaHA). This cutting-edge filler aims to set new standards in the aesthetic industry while showcasing the advanced capabilities of Chinese regenerative materials.

Engaging with Leading Clinicians

The congress attracted over 2,500 participants from around the globe, including professionals from the United States, Germany, Switzerland, and various Middle Eastern countries. Aphranel stood out by collaborating with prominent Chinese clinicians like Dr. Wang Wenting from Guangzhou Yestar and Dr. Chen Lorraine from Shanghai LELITE M. They presented groundbreaking concepts in regenerative materials and injection protocols that promise to enhance therapeutic outcomes and patient satisfaction.

The discussions centered on two main proprietary technologies:
1. ACD-MT Microm Sphere Technology: Inspired by the structure of raspberries, this technique focuses on an innovative approach to immediate shaping and controlled, long-term collagen regeneration.
2. PCD-ETT Physical Gel Cross-Linking Technology: This method ensures precise degradation profiles for optimal safety and efficacy.

These technologies aim to provide a balanced approach to aesthetic treatment, emphasizing immediate results while supporting skin rejuvenation over time.

Real-time Demonstrations and International Recognition

During the congress, Dr. Wang offered a live demonstration of injection techniques, highlighting the importance of selecting the appropriate layer and dosage control. Dr. Chen shared a strategic framework that focuses on depth and superficial aspects, emphasizing a comprehensive approach to aesthetic interventions. Their contributions received commendations from international peers and were featured on Saudi state television.

This collaboration reflects the growing integration of Chinese aesthetic technologies into the global market, underscoring the capabilities of the Chinese aesthetic industry from product development to complex technical applications.

Expanding International Reach

In addition to the congress activities, the Aphranel team visited local aesthetic institutions to engage in technical exchanges about regenerative materials and protocol design. This initiative positions the MagiCCrystal CaHA as a shared platform for professional dialogue between Chinese and Saudi aesthetic practitioners. Aphranel's participation at SAAM 2025 is a testament to their commitment to fostering international partnerships and enhancing global access to advanced aesthetic technologies.

With a strong technological foundation and domestic clinical validation, Aphranel is poised for international expansion. Their drive toward establishing a significant ‘Chinese momentum’ in the global aesthetic market is reinforced by a focus on collaborative efforts and innovative product offerings. The company aims not only to provide advanced materials and techniques to global practitioners but also to contribute meaningfully to the global aesthetic landscape.

As the aesthetic field continues to evolve, Aphranel's innovations like MagiCCrystal CaHA are set to play a vital role in advancing the standards of care for patients worldwide. Clinicians interested in the product must consider local regulations and guidelines, as availability, indications, and regulatory status can vary across different markets.